Midas Pharmasec (Delisted) results

BSE: 530257

Last traded ₹28.55 on 28 Jun 2011

Delisted on 3 Aug 2011.

Results for the quarter to Mar 2011

Standalone: the listed company alone, without its subsidiaries. ₹ crore.Midas Pharmasec annual results and balance sheet

Revenue
₹0.21 Cr+37.4% on a year ago · −2.7% on the quarter before
Net profit
₹0.14 Cr+84.6% on a year ago · +2.9% on the quarter before
Net margin
67.6%

From revenue to net profit, ₹ crore

  1. Revenue0.2
  2. Finance costs0.0
  3. Profit before tax0.2
  4. Tax0.0
  5. Net profit0.1

Midas Pharmasec results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2011. Results for the quarter to Jun 2011 were due by 14 Aug 2011, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2007Dec 2007Mar 2008Jun 2008Sep 2008Dec 2008Mar 2009Jun 2009Q1Sep 2009Dec 2009Mar 2010Jun 2010Sep 2010Dec 2010Mar 2011
Revenue from operations––−0.12−0.06−0.01−0.010.00–––0.16––0.220.21
Depreciation and amortisation0.000.000.000.000.00–0.00––––––––
Other income––––––0.01–0.050.04–0.090.10––
Finance costs––––––––––––––0.02
Profit before tax−0.02−0.02−0.29−0.07−0.02−0.04−1.03–0.030.030.110.070.080.170.18
Tax––––––0.00–––0.030.010.010.030.03
Tax rate––––––––––29.1%18.2%18.4%18.6%18.6%
Net profit−0.02−0.02−0.29−0.07−0.02−0.04−1.03–0.030.030.080.050.060.140.14
Net margin––246.6%117.9%242.9%360.0%1,02,500.0%–––50.3%––63.9%67.6%
Earnings per share––––––––₹0.03₹0.03₹0.08₹0.05₹0.06₹0.14–
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Jun 2009.